In the present case, we report a patient with synchronous bilateral mucoepidermoid carcinoma of the parotid gland.
Case Report
A 53-year-old male patient was admitted to our clinic with a complaint of left preauricular painless swelling for 1 month. Physical examination revealed a 2×3-cm, firm, semi-mobile and painless lesion localized to the left pre-auricular area. Neck ultrasonography (US) revealed a 29×13×31-mm, anechoic, thick-walled cystic lesion with peripheral vascularization and echogenicity extending to the cyst lumen in the left parotid gland. Additionally, in the right parotid gland, a thin-walled, anechoic 10×7-mm, cystic lesion with indistinguishable boundaries was detected. Round, 12×8-mm, hypoechogenic lymph nodes with indistinguishable central echogenic hilum were also detected sonographically on the left side of the neck at the level 2 region. Contrast-enhanced magnetic resonance imaging (MRI) revealed a lobulated, irregular mass (32×22 mm) located in the anteroinferior segment of the superficial lobe of the left parotid gland, with areas of extensive central necrosis, septation, and peripheral wall enhancement and a pure cystic lesion lateral to the retromandibular vein in Mucoepidermoid carcinoma is the most common malignant tumor of the parotid; however, its synchronous occurrence in both of the parotid glands is extremely rare. Herein, we presented a case of 53-year-old man with bilateral synchronous mucoepidermoid carcinoma of the parotid gland treated with surgery. The patient mainly complained of a painless mass in the left parotid gland. A mass located in the right parotid gland was incidentally detected by imaging. Based on cytopathology, left total parotidectomy was performed while preserving the facial nerve with ipsilateral neck dissection, and 5 weeks later, right superficial parotidectomy was performed. At the 3-year follow-up, there was no recurrence in the parotid regions and the neck. A detailed examination for parotid masses is suggested for identifying possible occult synchronous tumors in the contralateral side or in other salivary glands. A close follow-up is also recommended for the risk of future occurrence of metachronous tumors. Keywords: mucoepidermoid carcinoma, parotid gland, bilateral, synchronous, salivary gland the right parotid gland (Figs. 1, 2 ). The morphology of the upper jugular lymph nodes was reported as benign in MRI. Fine needle aspiration biopsy (FNAB) of the left parotid mass was reported as mucoepidermoid carcinoma. FNAB of the right parotid mass was reported as cytology with lymphocytes and epithelial and myoepithelial cells.
The patient was scheduled for staged left and right parotidectomy. On the first stage, left total parotidectomy was performed while preserving the facial nerve. The intraoperative frozen section confirmed mucoepidermoid carcinoma, and left neck dissection (levels 1, 2, 3, and 4) was also performed. The facial nerve functions were normal postoperatively. Five weeks later, the right parotid mass was excised through superficial parotidectomy. The intraoperative frozen section of the lesion revealed low-grade mucoepidermoid carcinoma. Owing to the histological grade of the tumor, neck dissection was not performed. The right facial nerve functions were also intact postoperatively.
The final histopathology of left and right surgical specimens confirmed the frozen section findings and was reported as intermediate-and low-grade mucoepidermoid carcinomas, respectively (Figs. 3, 4) . The pathology of the left neck dissection specimen revealed nonmetastatic lymphadenopathies. Further therapy was not considered due to tumor-free surgical margins and negative cervical lymph nodes. At the 3-year follow-up, the patient's postoperative course was uneventful without evidence of recurrence and metastasis.
Discussion
Bilateral malignant salivary tumors of the parotid glands may be synchronous or metachronous. [7] Synchronous tumors are defined as separate but simultaneous neoplasms and usually have a tendency of the same histologic type. [6] Whartin's tumor, pleomorphic adenoma, acinic cell carcinoma, adenocarcinoma, and myoepithelial carcinoma are among the previously reported bilateral synchronous tumors of the parotid gland. [6, 8] The most common histopathologic type is acinic cell carcinoma, which accounts for six previously reported cases. [9] [10] [11] [12] [13] [14] [15] Two cases of adenocarcinoma have been reported. [16, 17] Bilateral synchronous mucoepidermoid carcinoma of the parotid gland is extremely rare; only two cases have been reported previously. [1, 6] Metachronous bilateral mucoepidermoid carcinoma of the parotid gland is also rare, and only two cases have been reported previously. [3, 4] US provides bilateral evaluation of the parotid gland and contributes to the diagnosis of bilateral parotid masses. US and FNAB contribute to the diagnostic work-up of parotid neoplasms. [18] The malignancy detection rate of ultrasound-guided FNAB for parotid tumors is remarkable, whereas its diagnostic accuracy in tumor typing and grading is low. [19, 20] Intraoperative frozen sections have been reported to be superior in tumor typing and grading in comparison to FNAB. [19, 20] In the present case, FNAB clarified the left parotid mass as mucoepidermoid carcinoma but was inconclusive for the diagnosis of the right parotid mass.
The histological grade is considered as the most important factor in determining the management and predicting the outcome in mucoepidermoid carcinoma of the parotid gland. [21, 22] Mucoepidermoid carcinomas are histopathologically classified as low-, intermediate-, and high-grade. Low-grade mucoepidermoid carcinomas usually mimic benign tumors but still have the potential of local invasion and distant metastasis. The cystic component less than 20 %, neural invasion, necrosis, anaplasia, and intense mitotic activity are the histopathologic features that characterize high-grade tumors. High-grade mucoepidermoid carcinomas are associated with increase in locoregional invasion and metastasis rates. In a previous study, the 5-year disease-specific survival rates for low-, intermediate-, and high-grade mucoepidermoid carcinoma among 2.400 pa-tients were reported as 98.8%, 97.4%, and 67.0%, respectively. [21] The histological grade of a tumor may not be clearly defined using intraoperative frozen sections in all cases. In the present case, the intraoperative frozen section confirmed mucoepidermoid carcinoma in the left parotid gland but was inconclusive for the tumor grade. However, the intraoperative frozen section was conclusive for typing and grading of the right parotid mass.
Superficial parotidectomy is performed for treating lowgrade mucoepidermoid carcinoma of the superficial lobe of the parotid gland. [23] The suggested management for intermediate-grade mucoepidermoid carcinoma is excision of the lesion with negative surgical margins using total parotidectomy with preservation of the facial nerve. Selective neck dissection in N0 patients is recommended both for intermediate-and high-grade mucoepidermoid carcinomas. [23] In the present case, the management of intermediate-grade mucoepidermoid carcinoma in the left parotid gland was accomplished with total parotidectomy along with lateral neck dissection, whereas that of low-grade mucoepidermoid carcinoma in the right parotid gland was accomplished with superficial parotidectomy.
Conclusion
The diagnosis of malignant tumors of the parotid gland warrants a detailed examination. US is the first choice in imaging modalities. MRI and/or computerized tomography are suggested to determine the expanse of malignant tumors or the presence of metastatic lymph nodes. The radiographic images should be carefully analyzed to identify the possible occult synchronous tumors in the contralateral parotid gland and other salivary glands. FNAB and intraoperative frozen sections contribute to tumor typing and grading for the establishment of a surgical plan. Surgical removal is recommended for the management of synchronous bilateral parotid mucoepidermoid carcinoma, as likewise for all benign and malignant tumors of the salivary glands. A close clinical follow-up is also suggested for the risk of future occurrence or recurrences of metachronous tumors.
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